Effect of the GLP-1 Receptor Agonist Lixisenatide on Counter-Regulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes.
(2016) In Diabetes Care 39(2). p.242-249- Abstract
- Counter-regulatory responses are critical to prevent hypoglycemia in subjects with type 2 diabetes. This is particularly important in insulin-treated patients. This study explored the effect of the glucagon-like peptide 1 receptor agonist lixisenatide on the hormonal counter-regulatory responses to insulin-induced hypoglycemia when added to basal insulin therapy in subjects with type 2 diabetes.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8243127
- author
- Farngren, Johan LU ; Persson, Margaretha LU and Ahrén, Bo LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetes Care
- volume
- 39
- issue
- 2
- pages
- 242 - 249
- publisher
- American Diabetes Association
- external identifiers
-
- pmid:26537183
- wos:000368516200016
- scopus:84962110250
- pmid:26537183
- ISSN
- 1935-5548
- DOI
- 10.2337/dc15-1274
- language
- English
- LU publication?
- yes
- id
- 65ce3d62-4824-495e-a916-ea9b57093ca5 (old id 8243127)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26537183?dopt=Abstract
- date added to LUP
- 2016-04-01 10:16:05
- date last changed
- 2024-10-07 00:44:16
@article{65ce3d62-4824-495e-a916-ea9b57093ca5, abstract = {{Counter-regulatory responses are critical to prevent hypoglycemia in subjects with type 2 diabetes. This is particularly important in insulin-treated patients. This study explored the effect of the glucagon-like peptide 1 receptor agonist lixisenatide on the hormonal counter-regulatory responses to insulin-induced hypoglycemia when added to basal insulin therapy in subjects with type 2 diabetes.}}, author = {{Farngren, Johan and Persson, Margaretha and Ahrén, Bo}}, issn = {{1935-5548}}, language = {{eng}}, number = {{2}}, pages = {{242--249}}, publisher = {{American Diabetes Association}}, series = {{Diabetes Care}}, title = {{Effect of the GLP-1 Receptor Agonist Lixisenatide on Counter-Regulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes.}}, url = {{https://lup.lub.lu.se/search/files/7500745/8243127.pdf}}, doi = {{10.2337/dc15-1274}}, volume = {{39}}, year = {{2016}}, }